– OmniRx® Automated Medication Dispensing System Receives Top KLAS Award for the 8th Consecutive Year
DUBAI, United Arab Emirates, Oct. 20, 2013 /PRNewswire – Omnicell, Inc. (NASDAQ: OMCL) a leading provider of medication and supply management solutions and analytics software for healthcare facilities, today announced that it was named the number one overall pharmacy equipment vendor in the KLAS 2013 Medical Equipment & Infrastructure Report. KLAS, a leading independent healthcare research firm, compared the performance of all pharmacy automation equipment vendors in its annual rankings. Omnicell also received the prestigious “Best in KLAS” customer preference award for Automated Medication Dispensing Units.
This marks the eighth consecutive year the OmniRx® automated medication dispensing system achieved the top ranking in this category from KLAS. The annual “Best in KLAS” award for highest-performing technology vendors is based on interviews with executives and clinicians from over 4,500 hospitals and 2,500 clinics.
Omnicell’s OmniRx medication dispensing system helps hospitals address ever-changing healthcare regulations and is designed to increase patient safety and workflow efficiency. OmniRx received the highest scores among medication dispensing systems for delivery of new technology and proactive service.
“Clinicians recognize the critical role that healthcare providers play in improving healthcare delivery,” says Adam Gale, KLAS president. “Thus, a growing number of hospital executives are weighing in on vendor performance. It speaks volumes that they want to be heard and be counted. And vendors are listening.”
Omnicell’s central pharmacy products also received top ratings in three categories in 2013. For the fourth consecutive year, Omnicell’s WorkflowRx™ Carousel was named category leader in the Pharmacy Automation: Medication Carousel category. Omnicell’s WorkflowRx Medication Packager was also named category leader in the High-Volume Unit Dose Packaging rankings. In a new pharmacy automation category for 2013, Controlled Substance Management Systems, Omnicell’s Controlled Substance Management System (CSM) was named category leader.
Omnicell’s WorkflowRx Carousel is designed to increase productivity and reduce costs in the central pharmacy by providing greater control and tracking of medications, improved dispensing accuracy and dynamic usage-based reordering of all pharmacy stock. In the KLAS “Buy Again” category, 95 percent of hospital executives indicated that they would purchase Omnicell’s WorkflowRx Carousel again.
As an integral part of the Omnicell WorkflowRx Carousel solution, the high speed Omnicell Medication Packager creates patient-ready, bar-code labeled medication packages from bulk stock. The Medication Packager enables pharmacies to improve dispensing accuracy and implement bar code medication systems at the bedside to help prevent medication errors. The Omnicell medication packaging system plays a vital role in streamlining central pharmacy operations and automating manual, labor-intensive processes while increasing the utilization of returned inventory to the pharmacy with the use of Intelligent Order Routing (IOR).
Omnicell’s Controlled Substance Management System (CSM), shares a database with other G4 Unity solutions and is designed to enable true closed-loop accountability of controlled substances and provide consistent patient, user and formulary information across pharmacy automation systems.
“There is no more powerful validation of the value of our products and services than to be overtly recognized by our customers via KLAS,” said Marga Ortigas-Wedekind, Omnicell executive vice president, global marketing and product development. “Knowing that our users have expressed such confidence in Omnicell both humbles and continuously inspires us to do even better for them by providing a superior customer experience.”
KLAS is a research firm on a global mission to improve healthcare delivery by enabling providers to be heard and counted. Working with thousands of healthcare executives and clinicians, KLAS gathers data on software, services, medical equipment, and infrastructure systems to deliver timely reports, trends, and statistical overviews. The research directly represents the provider voice and acts as a catalyst for improving vendor performance. KLAS was founded in 1996, and their staff and advisory board average 25 years of healthcare information technology experience. Follow KLAS on Twitter at www.twitter.com/KLASresearch.
For over 20 years the mission of Omnicell (NASDAQ: OMCL) has been creating new efficiencies to improve patient care, anywhere it is delivered. Omnicell is a leading supplier of comprehensive automation and business analytics software solutions for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home.
Since 1992, more than 2,600 Acute Care customers worldwide have utilized Omnicell’s medication automation, supply chain and analytics solutions to increase operational efficiency, reduce errors, deliver actionable intelligence and improve patient safety. Omnicell Non-Acute Care solutions, including its MTS Medication Technologies brand, provide innovative medication adherence packaging solutions that can reduce costly hospital readmissions and enable approximately 6,000 institutional and retail pharmacies worldwide to maintain high accuracy and quality standards in medication dispensing and administration while optimizing productivity and controlling costs.
For more information about Omnicell, Inc. please visit www.omnicell.com.
OMCL – G
- All Omnicell news releases (financial, acquisitions, products, technology etc.) are issued exclusively by PR Newswire and are immediately thereafter posted on the Company’s external website, omnicell.com.
- Omnicell and the Omnicell logo design are registered trademarks of Omnicell, Inc. WorkflowRx™ Carousel is a trademark of Omnicell, Inc.
- All other brand or product names may be trademarks or registered trademarks of their respective companies.